FRSX trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes FRSX achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 3 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 22, 2026, Foresight Autonomous Holdings Ltd. (FRSX) has a Wall Street consensus price target of N/A, based on estimates from 3 covering analysts. The company has a market capitalization of $246145.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, FRSX trades at a trailing P/E of -0.2x. Analysts expect EPS to grow +90.9% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
INVZInnoviz Technologies Ltd. | $129M | $0.58 | $6.00 | +930.9% | Buy | — | 5 |
OUSTOuster, Inc. | $3.0B | $46.57 | $56.00 | +20.2% | Hold | — | 9 |
AEVAAeva Technologies, Inc. | $1.5B | $24.39 | $8.74 | -64.2% | Buy | — | 8 |
LAZRLuminar Technologies, Inc. | $2M | $0.06 | — | — | — | — | — |
LIDRAEye, Inc. | $67M | $1.45 | $12.00 | +727.6% | Hold | — | 4 |
MVISMicroVision, Inc. | $121M | $0.36 | $5.00 | +1272.9% | Buy | — | 8 |
AEYEAudioEye, Inc. | $79M | $6.31 | — | — | — | — | — |
KOPNKopin Corporation | $902M | $4.93 | $7.75 | +57.2% | Buy | — | 7 |
CEVACEVA, Inc. | $1.4B | $49.72 | $45.40 | -8.7% | Buy | 94.2x | 25 |
MBLYMobileye Global Inc. | $6.9B | $8.46 | $13.32 | +57.4% | Buy | 30.6x | 26 |
Quick answers to the most common questions about buying FRSX stock.
The consensus price target for FRSX is $N/A, close to the current price of $1.69 (N/A% implied move). Based on 3 analyst estimates, the stock appears fairly valued near current levels.
FRSX has a consensus rating of "Buy" based on 3 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
FRSX's current price is $1.69 with a consensus target of $N/A (N/A% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
The most bullish Wall Street analyst has a price target of $N/A for FRSX, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. These targets typically reflect 12-month expectations.
FRSX is lightly followed, with 3 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month FRSX stock forecast based on 3 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy".
FRSX appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
FRSX analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.